Save time and get answers to complex questions with AI chat
What are the liver enzyme requirements for starting terbinafineWhen does the apixaban patent expire?When does the patent expire on ibranceAdefovir dipivoxil discount cardIs liver function monitoring necessary with lipitor
See the DrugPatentWatch profile for Natalizumab
Natalizumab (brand name Tysabri) is a high‑cost biologic used mainly for relapsing‑remitting multiple sclerosis and Crohn’s disease. The pricing can vary depending on the country, the payer, and whether you’re buying a vial, a pre‑filled syringe, or an infusion kit. Here’s a general snapshot of what you’re likely to see:
Average Wholesale Price (AWP)
Patient‑Facing Costs
Manufacturer Assistance
Generic/Alternative Options
While the list price of natalizumab sits around $35k–$40k per year in the U.S., most patients do not pay that amount. Insurance, Medicare, or manufacturer assistance typically bring the real cost down to a few hundred dollars (or even zero) per infusion. If you’re trying to figure out your exact out‑of‑pocket expense, it’s best to call your infusion center and insurance provider with your policy ID on hand.
Other Questions About Natalizumab :